PhD (2011) in Pharmacy (Microbiology), Universidade de Lisboa
Postdoctoral Fellow, Faculty of Pharmacy, Universidade de Lisboa
Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
-Search for new compounds with anti-HIV activity;
-Development of microbicides for the prevention of HIV infection;
-Characterization of HIV-1 diversity and investigation of the origin and epidemiological history of HIV-1 in Portugal and Portuguese Speaking African Countries;
-Study of the impact of genetic diversity and molecular epidemiology in diagnosis, disease progression and susceptibility to antiretroviral therapy;
-Nature, dynamics and prevalence of transmitted drug resistance mutations in untreated HIV-1 infected patients from Portuguese Speaking African Countries;
Bártolo I, Diniz R, Borrego P, Ferreira JP, Bronze MR, Barroso H, Pinto R, Cardoso C, Pinto JF, Diaz RC, Broncano PG, Muñoz-Fernández MA, Taveira N. Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women. PlosOne 2018; PONE-D-18-05860R1.
Romero-Severson EO, Bulla I, Hengartner N, Bártolo I, Abecasis A, Azevedo-Pereira JM, Taveira N, Leitner T. Donor-Recipient Identification in Para- and Poly-phyletic Trees Under Alternative HIV-1 Transmission Hypotheses Using Approximate Bayesian Computation. Genetics 2017; 207: 1089-101.
Bártolo I, Calado R, Borrego P, Leitner T, Taveira N. Rare HIV-1 subtype J genomes and a new H/U/CRF02_AG recombinant genome suggests an ancient origin of HIV-1 in Angola. AIDS Res Hum Retroviruses 2016; 32: 822-8.
Pineda-Peña AC, Varanda J, Sousa JD, Theys K, Bártolo I, Leitner T, Taveira N, Vandamme AM, Abecasis AB. On the contribution of Angola to the initial spread of HIV-1. Infect Genet Evol 2016; 46: 219-22.
Bártolo I, Zakovic S, Martin F, Palladino C, Carvalho P, Camacho R, Thamm S, Clemente S Taveira N. HIV-1 Diversity, Transmission Dynamics and Primary Drug Resistance in Angola. PLoS One 2014; 9:e113626.